This Weeks Cartoon by Theresa L. Garnero, ARNP, CDE.

Researchers say they discovered 9020 undiagnosed diabetics and 11,853 with impaired glucose tolerance, during screening for the massive NAVIGATOR (Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research) trial.

Seattle researchers will soon begin testing a way to stave off diabetes by tripping up the immune system with the help of mouse cells and will try to extend the honeymoon period for Type 1 diabetes indefinitely.

Risk of death, congestive heart failure or major adverse cardiovascular events was higher in patients who took muraglitazar. This information comes after the FDA advisory committee voted to recommend approval.

Endocrinologist-supported intervention improved primary care diabetes management.

Losing weight may be more important than exercise when it comes to being heart healthy in young adulthood.

New studies shows a 15% reduction for the risk of diabetes for every year of lactation.

Children assigned rosiglitazone lowered A1c by .25% over those on metformin but had average weight gain of 3 kg vs. no weight gain among those assigned metformin.

Diabetes, long known to be a costly disease because of high medical expenses and lost wages, can also take a big bite out of the local economy, according to a study.

Women with type 2 diabetes face an increased risk of urinary urge incontinence, but 17 percent of incontinence of any quantity and nearly 15 percent of severe incontinence can be avoided with the prevention of diabetes.